FOLR1‐stabilized β‐catenin promotes laryngeal carcinoma progression through EGFR/AKT/GSK‐3β pathway
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Huawei Tuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Taihe Hospital, Hubei University of Medicine, Shiyan, China. Hauptthemen laut MEDLINE: beta Catenin, Head and Neck Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Folate receptor 1 (FOLR1) is overexpressed in numerous epithelial malignancies; however, its role in laryngeal squamous cell carcinoma (LSCC) remains unclear. In the present study, we demonstrated that FOLR1 messenger RNA and protein expression levels were higher in LSCC tissues than in the adjacent normal tissues. Additionally, FOLR1 promoted the proliferation and migration of LSCC cells, whereas small interfering RNA‐mediated knockdown of β‐catenin abolished these effects. Moreover, FOLR1 stabilizes β‐catenin by inhibiting its ubiquitination and degradation. Furthermore, blocking the interaction between epidermal growth factor receptor (EGFR) and the EGFR/AKT/glycogen synthase (GSK)3β signaling axis both abolished FOLR1's effects on the expression and nuclear aggregation of β‐catenin. In summary, our work reveals a novel mode in which FOLR1 promotes the proliferation and migration of LSCC by enhancing the stability and nuclear translocation of β‐catenin through the EGFR/AKT/GSK3β axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
- Department of Dermatology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China.
- Department of Pathology, School of Basic Medical Science, Hubei University of Medicine, Shiyan, China.
ORCID-Profile: Huzi Zhao
Zitieren
APA
Tuo, H., Li, X., Du, H., Li, M., Xu, C., Yu, Z., & Zhao, H. (2024). FOLR1‐stabilized β‐catenin promotes laryngeal carcinoma progression through EGFR/AKT/GSK‐3β pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23634
Vancouver
Tuo H, Li X, Du H, Li M, Xu C, Yu Z, et al. FOLR1‐stabilized β‐catenin promotes laryngeal carcinoma progression through EGFR/AKT/GSK‐3β pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23634
BibTeX
@article{Tuo2024,
author = {Tuo, Huawei and Li, Xuemei and Du, Haixia and Li, Man and Xu, Chenli and Yu, Zizhong and Zhao, Huzi},
title = {FOLR1‐stabilized β‐catenin promotes laryngeal carcinoma progression through EGFR/AKT/GSK‐3β pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23634}
}
EUVIMED